RxDoctor Payments Data

Heather Wheeler, MD

Family Medicine · Bozeman, MTNPI 1801800370

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 42.0% of the total. Among family medicine clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,346in general payments, 2019–2025

Across 75 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$566
  • Lilly USA, LLC$123
  • Novo Nordisk$105
  • GSK$104
  • AstraZeneca$92
  • E.r. Squibb & Sons, L.L.C.$64
  • plus $292 from 10 others

What the payments were for

  • Food & beverage$1,346100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,346 in reported general payments places this provider in the 90th percentile of 426 family medicine providers in Montana.

See all family medicine providers in Montana

Medicare billing

Part B allowed, 2024
$53,848
Medicare patients
91
Services billed
1,617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban25$30,030
OzempicSemaglutide13$11,949
Spiriva HandihalerTiotropium Bromide12$6,184
Estradiol27$1,645
Atorvastatin Calcium128$1,436
Rosuvastatin Calcium74$1,312
Levothyroxine Sodium121$1,002
Losartan Potassium90$814
Gabapentin45$505
Duloxetine Hcl27$441
Potassium Chloride17$414
Tramadol Hcl22$400
Metoprolol Succinate21$369
Metformin Hcl53$281
Zolpidem Tartrate17$274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$57$30,03025 claims
Novo NordiskOzempic$105$11,94913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 426 family medicine providers in Montana.

Other family medicine in Bozeman

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →